Caxton Corp as of March 31, 2024
Portfolio Holdings for Caxton Corp
Caxton Corp holds 11 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xeris Pharmaceuticals (XERS) | 64.4 | $11M | 5.1M | 2.21 | |
| Rezolute Com New (RZLT) | 19.2 | $3.4M | 1.3M | 2.55 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 5.5 | $971k | 1.9k | 523.16 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 2.4 | $428k | 1.0k | 420.32 | |
| Kyverna Therapeutics (KYTX) | 2.2 | $394k | 16k | 24.84 | |
| Molecular Templates Com New (MTEMQ) | 1.7 | $307k | 137k | 2.24 | |
| Mind Medicine Mindmed Com New (MNMD) | 1.6 | $273k | 29k | 9.40 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.3 | $226k | 16k | 14.30 | |
| Lexeo Therapeutics (LXEO) | 0.9 | $162k | 10k | 15.68 | |
| Compass Therapeutics (CMPX) | 0.5 | $86k | 44k | 1.98 | |
| Adicet Bio | 0.2 | $41k | 18k | 2.35 |
